TCF7L2 and type 2 diabetes mellitus: Importantly, the T2DM risk associated with the TCF7L2 SNP has been linked to complications of the disease and has been shown to influence the effectiveness of oral hypoglycemic agents, such as sulfonylureas, which stimulate insulin release from the pancreas [166].